Curative treatment of esophageal cancer; an evidenced based review (Q38119170)

29 August 2017

title

Curative treatment of esophageal cancer; an evidenced based review (English)

1 reference

29 August 2017

1 reference

Ravi Shridhar

1 reference

29 August 2017

Reza Imani-Shikhabadi

1 reference

29 August 2017

Bonnie Davis

1 reference

29 August 2017

Oscar A Streeter

1 reference

29 August 2017

Charles R Thomas

1 reference

29 August 2017

publication date

1 December 2013

1 reference

Journal of gastrointestinal cancer

29 August 2017

published in

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

375-384

1 reference

29 August 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Oesophageal squamous cell carcinoma: II. A critical review of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves es

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan clinical oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Staging investigations for oesophageal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Outcomes of Patients With Esophageal Cancer Staged With [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Are patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Hospital volume and surgical mortality in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-013-9511-9

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

21 January 2018

1 reference

12 December 2020

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

12 December 2020

Preoperative radiotherapy for esophageal carcinoma

1 reference

12 December 2020

Results of radical radiotherapy of squamous cell carcinoma of the oesophagus

1 reference

12 December 2020

The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial

1 reference

12 December 2020

The results of surgery and radiotherapy in the treatment of small carcinomas of the thoracic oesophagus

1 reference

12 December 2020

Radiotherapy of oesophagus cancer. A review of 136 cases treated at the Institut Bordet (author's transl)

1 reference

12 December 2020

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma

1 reference

12 December 2020

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

1 reference

12 December 2020

Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study

1 reference

12 December 2020

Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery

1 reference

12 December 2020

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901

1 reference

12 December 2020

Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus

1 reference

12 December 2020

Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans

1 reference

12 December 2020

The Role of Radiation Therapy in the Management of Esophageal Cancer

1 reference

12 December 2020

Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus

1 reference

12 December 2020

Induction chemotherapy in the treatment of patients with carcinoma of the esophagus

1 reference

12 December 2020

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

12 December 2020

[Meta-analysis of postoperative adjuvant chemotherapy for localized esophageal carcinoma]

1 reference

12 December 2020

Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research

1 reference

12 December 2020

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

12 December 2020

Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study

1 reference

12 December 2020

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

12 December 2020

Management of carcinoma of the esophagus: the role of radiotherapy

1 reference

12 December 2020

5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research

1 reference

12 December 2020

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

12 December 2020

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus

1 reference

12 December 2020

Improved Outcomes in the Management of Esophageal Cancer with the Addition of Surgical Resection to Chemoradiation Therapy

1 reference

12 December 2020

Follow-up results after resection of thoracic esophageal carcinoma

1 reference

12 December 2020

Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography

1 reference

12 December 2020

Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group

1 reference

12 December 2020

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy v

1 reference

12 December 2020

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial

1 reference

12 December 2020

10.1007/S12029-013-9511-9

Identifiers

DOI

1 reference

29 August 2017

1 reference